MindWalk Holdings Corp.
- HYFT
- NASDAQ
- Biotechnology
- AI Drug Discovery
- Multi-omics Biotech
- Therapeutics R&D
$1.32
Today +0.76%Quote Oct 19, 2026, 08:00 PM UTC
0.00%over the last month
Max drawdown −15.5%From 1-month high −15.5%3 months −8.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About MindWalk
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics.
Where the money comes from
Q3 2024 revenue $24.3M
- Project Revenue$22.2M91.6%
- Product Sales$2.0M8.4%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
76
Founded
1983
Market value
$62.2M
Quote Oct 19
Analyst target
$5.00
+278.8% from here
Floor
$1.29
2.5% below price
Resistance
$1.43
8.0% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HYFTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free